Zoledronic Acid bulk supplier for pharma manufacturers

Zoledronic Acid Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 5 mg/100 mL, 4 mg/5 mL (reconstituted)

Reference Brands: Reclast, Zometa,Aclasta,Zoldria (India)

Zoledronic Acid (Zometa, Reclast) treats osteoporosis, bone metastases, and cancer-related hypercalcemia. Available in 4 mg and 5 mg IV formats for B2B export.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Zoledronic Acid Injection is a powerful IV bisphosphonate used for the treatment of osteoporosis, Paget’s disease, bone metastases, and hypercalcemia of malignancy. Available as 5 mg/100 mL ready-to-infuse solution (Reclast/Aclasta) and 4 mg/5 mL concentrate (Zometa), it ensures long-acting bone protection with annual or monthly dosing options. Trusted brands like Zometa, Reclast, and Aclasta are widely prescribed in the US and EU. Manufactured in GMP-certified facilities, Zoledronic Acid is available for global B2B distribution, with full regulatory documentation, COAs, and competitive bulk pricing.

Zoledronic Acid — third party manufacturing & bulk supply

Zoledronic Acid is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Zoledronic Acid is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Zoledronic Acid listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Zoledronic Acid →

Back to Listing

Frequently Asked Questions

Zoledronic Acid is used to treat and prevent bone complications in patients with cancers such as multiple myeloma and bone metastases from solid tumors. It is also used for the treatment of osteoporosis and Paget’s disease of bone by helping strengthen bones and reducing bone loss.

Zoledronic Acid Monohydrate is a synthetic bisphosphonate compound that works by inhibiting osteoclast-mediated bone resorption, which helps reduce bone breakdown and maintain bone density.

Common trade names include Zometa, Reclast, and Aclasta.

The original product was developed and manufactured by Novartis. Many pharmaceutical companies worldwide now produce generic versions.

The generic name is Zoledronic Acid Monohydrate.

Brand names include Zometa, Reclast, Aclasta, and several generic branded versions.

Zoledronic Acid injections are manufactured in several countries including the United States, Switzerland, India, and various EU pharmaceutical manufacturing hubs depending on the manufacturer.